Diagnosing male hypogonadism requires more than just recognizing symptoms—it involves careful blood testing, physical examination, and sometimes additional investigations to understand why testosterone levels are low and what treatment approach might work best.

Introduction: Who Should Seek Diagnostic Testing

Not every man needs to be tested for hypogonadism. Routine screening in men without symptoms is generally not recommended, except in certain situations. However, if you’re experiencing specific changes in your body or overall well-being, it may be time to talk with your doctor about testing.^[1]

Men who should consider seeking diagnostic evaluation include those experiencing decreased sex drive, problems with erections, unexplained fatigue, mood changes such as depression or irritability, or loss of muscle mass and strength. Other warning signs include shrinking testicles, hot flashes, or a noticeable decrease in facial and body hair. If you have difficulty concentrating, trouble sleeping, or notice changes in your physical appearance such as increased body fat or breast tissue development, these could also signal low testosterone.^[3]

Certain groups of men face higher risk and should be particularly attentive to these symptoms. Men over 45 years of age naturally experience gradual testosterone decline, though not all develop problematic symptoms. Those who are overweight or obese, have poorly managed type 2 diabetes, suffer from obstructive sleep apnea, or have chronic medical conditions like kidney disease or liver cirrhosis are more likely to develop low testosterone. Men with HIV/AIDS also face increased risk.^[4]

It’s important to understand that low testosterone can begin at different life stages, and the timing affects both symptoms and treatment options. Some men are born with conditions that prevent normal testosterone production. Others may experience delayed puberty during adolescence. Still others develop hypogonadism in adulthood, sometimes following injury, infection, or as a natural consequence of aging.^[1]

Classic Diagnostic Methods

Diagnosing male hypogonadism involves several steps, beginning with a thorough conversation with your doctor about your symptoms, medical history, and any medications you’re taking. Your doctor needs to know about all prescription and over-the-counter drugs, as some medications—particularly opiates and steroids—can lower testosterone levels. Major life changes, stress levels, and sexual problems should also be discussed openly.^[4]

Physical Examination

A complete physical examination is essential for proper diagnosis. Your healthcare provider will assess your sexual development by looking at body hair patterns, muscle mass, and the size and consistency of your testicles and scrotum. This examination helps determine whether your pubic hair, muscle development, and testicular size are typical for your age. The provider may also check for breast tissue development, known as gynecomastia, which can occur when testosterone levels are low.^[11]

During the physical exam, your doctor is looking for physical signs that correspond with your symptoms. The size of the testicles, for example, can provide important clues. Smaller than normal testicles might indicate a problem with testosterone production. The distribution of body fat, muscle mass, and hair growth patterns all provide visual evidence of how testosterone has been affecting your body over time.^[3]

Blood Tests for Testosterone Levels

Blood testing is the cornerstone of hypogonadism diagnosis. Your doctor will order blood tests to measure your testosterone levels, but the timing and interpretation of these tests require careful attention. Testosterone levels naturally fluctuate throughout the day, typically reaching their highest point in the early morning hours. For this reason, blood samples should be collected in the morning, usually between 7 and 10 a.m., to get the most accurate reading.^[11]

A single low reading is not enough to diagnose hypogonadism. Because testosterone levels can vary from day to day, your doctor will typically repeat the test on a separate morning to confirm that low levels are persistent. Most guidelines recommend obtaining at least two early morning samples showing low testosterone before making a diagnosis.^[2]

The normal range for total testosterone in adult men generally falls between 300 and 1,000 nanograms per deciliter (ng/dL), though this varies somewhat between laboratories. Most medical organizations consider levels below 300 ng/dL to be low, though some experts suggest that levels below 250 ng/dL are more definitively problematic. However, testosterone levels alone don’t tell the whole story—symptoms matter greatly in the diagnostic process.^[3]

It’s worth noting that what constitutes a “healthy” testosterone level depends on several factors including your age and individual circumstances. Older men typically have lower levels than younger men—this is a normal part of aging. A testosterone level that might be appropriate for a 60-year-old could be considered low for a 30-year-old. Healthcare providers consider both the number and your specific situation when interpreting results.^[4]

Additional Blood Tests

If your initial testosterone tests show low levels and you have corresponding symptoms, your doctor will likely order additional blood work to understand the underlying cause. These tests help distinguish between primary hypogonadism—where the problem originates in the testicles themselves—and secondary hypogonadism—where the issue lies in the brain structures that control testosterone production.^[2]

Tests for luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are particularly important. These hormones are produced by the pituitary gland at the base of your brain and signal your testicles to make testosterone and sperm. If testosterone is low but LH and FSH are high, this suggests primary hypogonadism—your brain is sending strong signals, but your testicles aren’t responding properly. If both testosterone and these hormones are low, this points to secondary hypogonadism—the problem is with the signaling system in the brain.^[7]

Your doctor may also check prolactin levels, another hormone produced by the pituitary gland. Elevated prolactin can suppress testosterone production and may indicate a pituitary tumor. Tests for other pituitary hormones might be ordered if a broader pituitary problem is suspected. Thyroid function tests are also common, as thyroid problems can affect testosterone levels and cause similar symptoms.^[7]

In some cases, doctors measure not just total testosterone but also bioavailable testosterone. While total testosterone includes all testosterone in your blood, some of it is tightly bound to proteins and unavailable for your body to use. Bioavailable testosterone represents the portion that’s free or loosely bound and actually available to affect your tissues. This measurement can be particularly helpful when total testosterone levels fall in the borderline range.^[3]

Semen Analysis

If you’re concerned about fertility or trying to conceive, a semen analysis may be performed. This test examines a sample of semen to check sperm count, movement, and structure. Low testosterone commonly affects sperm production, and this test can reveal the extent of the impact. Understanding your current fertility status is especially important if you’re considering treatment options, as some testosterone therapies can reduce or eliminate sperm production.^[11]

Imaging Studies

Depending on what initial tests reveal, your doctor might recommend imaging studies. If blood tests suggest a problem with the pituitary gland—the small gland at the base of the brain that controls testosterone production—a magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain may be ordered. These scans can identify tumors or other abnormalities affecting the pituitary or hypothalamus.^[11]

Pituitary imaging is particularly important if you have very low testosterone combined with low LH and FSH levels, if you have symptoms like persistent headaches or vision problems, or if prolactin levels are elevated. These findings might indicate a tumor pressing on the pituitary gland or nearby structures.^[7]

Genetic Testing

In certain situations, genetic studies may be recommended. This is particularly true for younger men with hypogonadism or those with features suggesting a genetic condition. Conditions like Klinefelter syndrome—where males are born with an extra X chromosome—are a common genetic cause of primary hypogonadism. A simple blood test called a karyotype can check your chromosomal makeup. Other genetic tests might be used to identify rarer inherited conditions affecting hormone production.^[11]

Diagnostics for Clinical Trial Qualification

When patients with hypogonadism are being considered for enrollment in clinical trials testing new treatments, the diagnostic requirements are often more stringent than those used in routine clinical care. Clinical trials need to ensure that all participants truly have the condition being studied, so they can accurately measure whether a treatment works.^[2]

Most clinical trials for male hypogonadism require documented low testosterone levels on at least two separate morning blood tests. The specific cutoff value may vary between studies, but many use 300 ng/dL as the upper limit for inclusion. Some trials may require even lower levels or specify that tests must be performed on consecutive days or within a specific time window.^[2]

Beyond testosterone measurements, clinical trials typically require participants to have clearly documented symptoms of hypogonadism. These might include decreased sex drive, erectile dysfunction, reduced muscle mass, or other characteristic features. Trial protocols often use standardized questionnaires or rating scales to assess symptoms objectively. This ensures that treatments are tested in men who actually suffer from the condition, not just in those with borderline lab values who feel perfectly healthy.^[2]

Additional blood work is standard in trial screening processes. Trials commonly measure LH and FSH to classify whether hypogonadism is primary or secondary, as different types may respond differently to treatment. Complete blood counts are performed to check for anemia or elevated red blood cell counts. Liver and kidney function tests ensure that participants can safely metabolize and eliminate the study drug. Prostate-specific antigen (PSA) testing is routine in trials involving older men, as testosterone therapy can affect prostate health.^[11]

Physical examination requirements in trials mirror clinical practice but are often more detailed and standardized. Testicular volume may be measured precisely using instruments called orchidometers. Body composition might be assessed using specialized imaging like dual-energy X-ray absorptiometry (DEXA) scans to measure bone density, muscle mass, and fat distribution accurately. These baseline measurements allow researchers to track changes during treatment with precision.^[11]

Some clinical trials exclude certain patient groups to ensure safety. Men with a history of prostate cancer, severe sleep apnea, congestive heart failure, or recent cardiovascular events may not be eligible. Those taking certain medications that affect testosterone levels or interfere with study measurements might also be excluded. These restrictions help researchers isolate the effects of the treatment being studied and protect participants from potential risks.^[2]

For trials studying treatments aimed at restoring fertility in men with hypogonadism, semen analysis is a critical diagnostic requirement. Baseline sperm counts, motility, and morphology are carefully documented before treatment begins. Men who retain normal sperm production despite low testosterone might be excluded from fertility-focused studies, while those with very low or absent sperm production become the target population.^[11]

Clinical trials may also require more frequent monitoring than routine care. Follow-up blood tests for testosterone and other hormones might be scheduled weekly or monthly rather than every few months. Regular physical examinations, blood pressure checks, and symptom assessments help researchers track both benefits and potential side effects closely. This intensive monitoring provides valuable safety data but also requires significant commitment from participants.^[2]